A novel human connexin gene (GJA11) was cloned from a genomic library. The open reading frame encoded a hypothetical protein of 294 amino acid residues with a predicted molecular mass of 31,933, hence referred to as connexin-31.9 (Cx31.9) or ␣11 connexin. A clone in GenBank TM containing the Cx31.9 gene localized to chromosome 17q21.2. Northern analysis of Cx31.9 showed a major 4.4-kilobase transcript, which was expressed at varying levels in all tissues analyzed. Two monoclonal antibodies generated against different domains of Cx31.9 recognized a 30 -33-kDa protein from cells overexpressing Cx31.9. Immunofluorescence of overexpressing cells indicated the presence of Cx31.9 between adjacent cells, consistent with its localization to gap junctions. Double voltage clamp analyses of Cx31.9-overexpressing cells, and of paired Xenopus oocytes injected with Cx31.9 cRNA, demonstrated junctional currents indicative of gap junction channel formation. In contrast to previously characterized connexins, Cx31.9 showed no voltage-dependent gating within a physiologically relevant range. Cx31.9 was detected in human tissues by immunoblot analysis, and immunofluorescence localized Cx31.9 expression to vascular smooth muscle cells. Furthermore, it was demonstrated that Cx31.9 interacted with ZO-1. Thus, Cx31.9 represents a novel connexin gene that in vivo generates a protein with unique voltage gating properties.
A novel human connexin gene (GJA11) was cloned from a genomic library. The open reading frame encoded a hypothetical protein of 294 amino acid residues with a predicted molecular mass of 31,933, hence referred to as connexin-31.9 (Cx31.9) or ␣11 connexin. A clone in GenBank TM containing the Cx31.9 gene localized to chromosome 17q21.2. Northern analysis of Cx31.9 showed a major 4.4-kilobase transcript, which was expressed at varying levels in all tissues analyzed. Two monoclonal antibodies generated against different domains of Cx31.9 recognized a 30 -33-kDa protein from cells overexpressing Cx31.9. Immunofluorescence of overexpressing cells indicated the presence of Cx31.9 between adjacent cells, consistent with its localization to gap junctions. Double voltage clamp analyses of Cx31.9-overexpressing cells, and of paired Xenopus oocytes injected with Cx31.9 cRNA, demonstrated junctional currents indicative of gap junction channel formation. In contrast to previously characterized connexins, Cx31.9 showed no voltage-dependent gating within a physiologically relevant range. Cx31.9 was detected in human tissues by immunoblot analysis, and immunofluorescence localized Cx31.9 expression to vascular smooth muscle cells. Furthermore, it was demonstrated that Cx31.9 interacted with ZO-1. Thus, Cx31.9 represents a novel connexin gene that in vivo generates a protein with unique voltage gating properties.
Most cells in vertebrate tissues are coupled by gap junction channels, which allow the transfer of low molecular mass substances (Ͻ1 kDa) between cells. The ability of cells to communicate in this manner is thought to be important for coordinating tissue growth, development, and physiological activities. Connexins are the sole proteins required for the formation of gap junctions (1) . Six connexin monomers form a hemichannel (connexon) on the cell surface, which can interact with a connexon from a neighboring cell, thus forming a channel linking the cytoplasm of the two cells.
A number of different connexin isoforms are found in vertebrates. The connexins characterized to date have distinct channel permeabilities and gating properties (2, 3) , as well as distinct cell and tissue expression patterns, which is presumed to orchestrate a spatially and temporally regulated diffusion of small molecules between cells. This has recently been demonstrated by studies of genetically altered mice, in which the expression of Cx43 1 was replaced by expression of Cx40 or Cx32. These mice differed functionally and morphologically from wild type mice, demonstrating that one connexin isoform cannot fully substitute for another (4) . Regulation of the diffusion of small molecules can be further modulated by combining different connexin isoforms in each hemichannel (heteromeric gap junctions) and by combining different hemichannels (heterotypic gap junctions), thus creating channels with highly specific permeability and gating properties.
All connexin isoforms are presumed to have a similar topology, which has been deduced from limited proteolysis and sitedirected antibodies (5) . The NH 2 -terminal and COOH-terminal domains are localized in the cytoplasm, and are connected by four transmembrane domains, two extracellular loops, and a cytoplasmic loop. The major diversity between different connexin isoforms is found in the length and amino acid sequences of the cytoplasmic loop and COOH-terminal domains. Two nomenclature systems are in use to designate members of the connexin family; one is based on the theoretical molecular mass of the proteins preceded by "Cx" (6) , and the other is based on sequence similarity analysis, in which clustering groups of connexins are designated by Greek letters, and individual connexins in each group by the order in which they were cloned (7). * This work was supported by a grant from the Danish Research Council (to P. A. N.) and by National Institutes of Health Grant EY12142 (to N. M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence (s) Most of the human connexins characterized so far have orthologues in mice (the organism with the most well characterized connexin expression), and presumably in all vertebrates.
Other proteins have been reported to interact with connexins, e.g. v-Src and c-Src (8 -10) , occludin (11) , tubulin (12) , and zona occludens protein-1 (ZO-1) (13, 14) . ZO-1 is a membraneassociated guanylate kinase family member, which was first found associated with tight junctions, and later shown to bind directly to the tight junction components occludin (15) and claudins (16) . Membrane-associated guanylate kinase proteins are thought to be involved in localizing cell surface proteins to specialized membrane domains (17) . They contain a varying number of PDZ (PSD-95, DLG, ZO-1) domains, a Src homology 3 domain, and an inactive guanylate kinase domain. PDZ domains bind to other proteins, mainly to the most COOH-terminal residues of the cell membrane proteins they recognize, although internal binding sequences have also been identified (18) . The second PDZ domain of ZO-1 has been shown to bind the COOH terminus of Cx43 (14) . Recently, Cx45 was also shown to interact with ZO-1, although it is not clear which domains are involved in this interaction (19, 20) .
The human genome sequencing project has revealed that 20 genes encoding putative connexins exist in human (21) . 2 However, at present it cannot be excluded that some of these sequences represent pseudogenes. Either the human genes themselves or their rodent homologues have been shown to encode proteins for 17 of the 20 genes. The characterization of these proteins, and especially their homozygous deletions in mice, has provided valuable understanding of several human diseases caused by mutations in connexin genes, such as congenital deafness, Charcot-Marie-Tooth disease, erythrokeratodermia viabilis, congenital cataracts, and congenital heart malformations (22) . With the purpose of understanding connexin function in further detail, we here report the cloning and functional characterization of a novel human connexin, Cx31.9, which we found expressed in vascular smooth muscle cells. Furthermore, we present data suggesting that Cx31.9 interacts with ZO-1.
EXPERIMENTAL PROCEDURES

Obtaining a Partial Cx31.9 cDNA and Genomic Clone
The human EST data base at NCBI (www.ncbi.nlm.nih.gov) was searched using the BLAST algorithm (23) with published connexin sequences. An EST clone (accession number AA915885) with similarity to connexins was obtained (Genome Systems, St. Louis, MO) and plasmid DNA isolated (Qiagen, Hilden, Germany). The plasmid was sequenced with T3, T7, and gene-specific primers (Invitrogen and MWG Biotech (High Point, NC)) on both strands. The insert of clone AA915885 was excised using EcoRI and NotI and used as a probe to screen 1 ϫ 10 6 clones from a human genomic liver gt-10 library (Stratagene, La Jolla, CA). Four genomic clones hybridized with the probe, and DNA was isolated from two of these. The DNA was digested with several restriction enzymes and used for Southern analysis with the AA915885 fragment probe. A 1949-bp BamHI hybridization-positive fragment was subcloned in pGEM7 (Promega, Madison, WI) and sequenced on both strands.
5Ј-RACE
Human testis cDNA containing 5Ј and 3Ј adaptors (Marathon cDNA, CLONTECH, Palo Alto, CA) was used as a template in PCR with the primer PN115 (5Ј-TCAGCATGACCACCAGCCAG-3Ј) from nucleotides 91-72 of the Cx31.9 sequence and primer AP1 from the cDNA adaptors, with Expand High Fidelity PCR system (Roche Molecular Biochemicals). PCR products were cloned into pGEM and sequenced on both strands.
Northern Blot Analysis
A probe encompassing nucleotides 619 -885 of the coding sequence of Cx31.9 was generated by PCR using the primers P32 (5Ј-ATCGAATT-CGCCGAGCTGGGCCACCTGC-3Ј) and P33 (5Ј-ATCCTCGAGCTAGA-TGGCCAGATCTCGGC-3Ј). Human MTN (multiple tissue Northern) blot I containing poly(A ϩ ) RNA (CLONTECH) was probed at 68°C using ExpressHyb buffer (CLONTECH) according to the instructions from the manufacturer, and the blot was washed to a stringency of 0.1ϫ SSC, 65°C. The blot was exposed to BioMax MS film (Eastman Kodak Co.) for 48 h at Ϫ80°C.
Constructs
Cx31.9-COOH-terminal GST Fusion Protein-The 1949-bp genomic BamHI Cx31.9 fragment was used as a template in PCR with the primers P32 (5Ј-ATCGAATTCGCCGAGCTGGGCCACCTGC-3Ј) and P33 (5Ј-ATCCTCGAGCTAGATGGCCAGATCTCGGC-3Ј), using Pfu Turbo (Invitrogen). The resultant 284-bp fragment was EcoRI/XhoI cloned into pGEX4T-1 (Amersham Biosciences, Stockholm, Sweden). The sequence was verified by sequencing.
Cx31.9-loop GST Fusion Protein-Using the BamHI genomic fragment as a template for a PCR reaction with Expand High Fidelity PCR system, with the primers P113 (5Ј-ATCGGATCCTACTCCATGCACCG-GGCAGG-3Ј) and P114 (5Ј-ATCGAATTCGTAGCAGCGGCGCGCGCG-3Ј), a product of 142 bp was generated. This fragment was BamHI/ EcoRI cloned into pGEX2-TK (Amersham Biosciences), and the sequence verified.
Cx31. 9 Untagged Expression Construct-The genomic 1949-bp BamHI fragment was cloned into BamHI-linearized pcDNA-3 (Invitrogen). This expression vector contains a cytomegalovirus promotor and a bovine growth hormone polyadenylation signal.
Cx31.9-eGFP Expression Construct-A SmaI/BglII genomic fragment containing the coding region of Cx31.9 except the most 3Ј 11 nucleotides was cloned in SmaI/KpnI-linearized pBluescript KSϩ/Ϫ (Stratagene) by the use of 5Ј-phosphorylated (5ЈP) oligonucleotides with the sequences 5ЈP-GATCTGGCCATCGGGGTAC-3Ј and 5ЈP-CCCGAT-GGCCA-3Ј to link the BglII and KpnI sites. This construct was excised from pBluescript using SacI and KpnI and cloned into SacI/KpnIlinearized eGFP-N1 (CLONTECH), to generate an open reading frame encoding Cx31.9 with a COOH-terminal eGFP tag. The vector, eGFP-N1, contains a cytomegalovirus promotor and a SV40 polyadenylation signal.
ZO-1 GST Fusion Proteins-PDZ domains were amplified by PCR using human ZO-1 cDNA and the following primers: PDZ-1F (5Ј-GGG-GGTCGACAATGGAGGAAACAGCTATATGG-3Ј), PDZ-1R (5Ј-CCCCG-AATTCCTAACGACTTACTGGTATGTT-3Ј), PDZ-2F (5Ј-GGGGGTCG-CAGTGGTCTCCAGCCAGCTT-3Ј), PDZ-2R (5Ј-CCCCGAATTCCTAA-TCAAGGACATTCAATAG-3Ј), PDZ-3F (5Ј-GGGGGTCGACAATGAAG-ATGGGATTTCTTCGG-3Ј), and PDZ-3F (5Ј-CCCCGAATTCCTATTCT-ACAATGCGACGATA-3Ј). PCR products were digested with SalI and EcoRI, subcloned and sequenced, followed by ligation into BamHI/ EcoRI-linearized pGEX-3X (Amersham Biosciences).
Cx31.9 Xenopus Expression Construct-The 1949-bp BamHI fragment containing Cx31.9 was cloned into BamHI-linearized pXLII (paw2pla). This vector was derived from pXBG-ev1, a derivative of pBS KSϪ containing the 5Ј-and 3Ј-UTR regions of the Xenopus laevis ␤-globin gene with an internal multiple cloning site. The correct orientation of the insert was verified by sequencing.
Generation of mAbs against Cx31.9
GST fusion proteins were obtained using standard procedures. Aliquots (50 g) were used to immunize female BALB/C mice intraperitoneally with Freund's complete adjuvant for the first immunization, and Freund's incomplete adjuvant (Sigma) for the following three immunizations. Three days after the final boost, mice were sacrificed, and spleen cells fused to mouse myeloma cell line X63Ag. Supernatants from the resultant hybridomas were screened against the GST fusion proteins by enzyme-linked immunosorbent assay, and positive wells were cloned and rescreened till monoclonality. Hybridomas were expanded in Hybridoma-SFM (serum-free medium; Invitrogen), and antibodies isolated with HiTrap Protein G columns (Amersham Biosciences) according to the instructions from the manufacturer. The use of mice for these experiments was approved by the Scripps Research Institute Animal Committee.
Generation of Cx31.9-overexpressing Cell Lines
Human embryonic kidney (HEK) 293 cells were grown in Dulbecco's modified Eagle's medium (DMEM; Invitrogen) containing 10% FCS, 2 mM L-glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin in a 37°C incubator with a moist atmosphere of 4% CO 2 . The cells were transfected with the Cx31.9 untagged expression construct using Superfect (Qiagen) according to the instructions from the manufacturer. After 24 h, the medium was exchanged to selective medium (0.8 mg/ml Geneticin (Invitrogen)) for 10 days. Surviving clones were then picked, expanded, and lysates screened by immunoblot with mAb 7G6 for expression of the connexin. Positive clones were reseeded, repicked and rescreened three or four times to obtain stable expression.
Immunoprecipitation Analyses
Cell lines were metabolically labeled overnight by incubation with 100 Ci of Tran 35 S-label (ICN, Costa Mesa, CA) in 5 ml of DMEM without L-methionine and L-cysteine/L-cystine (ICN), supplemented with 10% dialyzed FCS. Cells were then washed with PBS, and lysed in IP buffer (50 mM Tris, 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40, 0.25% deoxycholate, pH 8.0) or RIPA buffer (1 M NaCl, 2 mM EDTA, 0.1% SDS, 1% Triton X-100, 100 mM Tris-HCl, pH 7.4). Following incubation on ice for 15 min, lysates were clarified and incubated with primary antibodies bound to Protein A/G beads (Calbiochem, La Jolla, CA) (5 g of antibody/IP) overnight at 4°C. The beads were then washed extensively in IP buffer and proteins separated by SDS-PAGE, followed by staining with GelCode (Pierce) to visualize the amount of antibody. Gels were dried and exposed to BioMax MS film at Ϫ80°C for 12 h.
SDS-PAGE and Immunoblot Analyses
Samples were separated on 10 or 12.5% SDS-PAGE gels in Hoefer vertical gel apparatuses, followed by transfer to Protran 0.2-m pore size nitrocellulose membranes (Schleicher & Schuell). Membranes were stained with 0.2% Ponceau S in 1% acetic acid, blocked with 5% skimmed milk powder in TBST, and incubated with purified primary antibody (5-10 g/ml) in blocking buffer. Membranes were then washed in TBST, followed by incubation with horseradish peroxidase-conjugated secondary antibody (Bio-Rad). The antibodies were detected with chemiluminescence (SuperSignal West Pico, Pierce) by exposure to Biomax ML film (Eastman Kodak).
Human Samples
Human tissues were obtained from the National Cancer Institute Cooperative Human Tissue Network and from the National Disease Research Interchange. Surgical specimens of human brain, large intestine, heart, skeletal muscle, and aorta were homogenized in buffer containing 150 mM sucrose, 15 mM HEPES, 60 mM KCl, 5 mM EDTA, 1 mM EGTA, pH 7.9, and protease inhibitors. Following homogenization, Triton X-100 was added to a final concentration of 1%, and the homogenate incubated on ice for 1 h. The lysate was then centrifuged at 18,000 ϫ g at 4°C, and the supernatant used for SDS-PAGE and immunoblot analysis. The use of human material for these studies was approved by the Scripps Clinic, Scripps Green Hospital, and the Scripps Research Institute Human Subjects Committee.
Immunofluorescence: Cell Lines
Cells were grown on poly-L-lysine (Sigma)-treated glass coverslips, washed in PBS, and fixed in Ϫ20°C acetone or methanol for 6 min. Coverslips were blocked with 5% goat serum in PBS (blocking buffer), followed by incubations with primary antibodies overnight in blocking buffer at 4°C. mAbs 7G6 and 5G11 were used at 5-10 g/ml, and a commercial anti-ZO-1 polyclonal antibody (Zymed Laboratories, South San Francisco, CA) was used at 5 g/ml. Following washing with PBS, coverslips were incubated with fluorochrome-labeled secondary antibodies (Southern Biotech Associates Inc., Birmingham, AL), diluted 1:100, together with 50 nM To-Pro-3 to stain nuclei (Molecular Probes, Eugene, OR), in blocking buffer for 1 h. Washed slides were mounted with Fluoromount-G (Sigma), and images were collected using a Zeiss Axiovert confocal microscope. Surgical human tissue samples were frozen and imbedded in O.C.T. Four-m sections were cut on a cryostat and attached to Superfrost slides at Ϫ20°C. Tissues were fixed in 4% paraformaldehyde in PBS for 2 h at 4°C, followed by permeabilization with 0.1% Triton X-100 in PBS for 20 min at room temperature. Blocking, antibody incubations, and imaging were as described above. mAb 1E12 (IgM) against smooth muscle ␣-actinin was developed by Dr. Charles D. Little and co-workers, and mAb P2B2 (IgG1) against PECAM was developed by Drs. Elizabeth A. Wayner and Gregory Vercellotti. These mAbs were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the Department of Biological Sciences, University of Iowa (Iowa City, IA). For the co-localization studies, mAb 7G6 was detected with an anti-mouse ␥ chain-specific secondary antibody, which was cross-absorbed on mouse IgM, whereas mAb 1E12 was detected with a mouse IgM-specific antibody, which was cross-absorbed on mouse IgG (Southern Biotechnology Associates, Inc.).
Microinjections
Glass pipettes containing a capillary filament were pulled on a Brown-Flaming micropipette puller (Sutter Instrument Co., San Francisco, CA). Overnight cultures of Cx31.9-HEK cells and wt HEK cells were microinjected (Transjector 5246, Eppendorf, Madison, WI) with 4% Lucifer yellow, carboxyfluorescein, cascade blue (Molecular Probes, Eugene, OR), or 5% ethidium bromide (Sigma) in 1 M LiCl, including 2% Texas Red or FITC-labeled dextran (Molecular Probes, Inc.) to visualize the injected cell. The spread of dyes was monitored in a Zeiss Axiovert 100 fluorescent microscope.
Electrophysiology of Cx31.9 Expressed in Xenopus Oocytes
The Xenopus expression construct was linearized with SacI, and cRNA was generated by in vitro transcription with AmpliScripe T3 transcription kit in conjunction with a monomethylated cap analog m7G[5Ј]ppp[5Ј]G (Epicentre Technologies, Madison, WI). The size of the transcript was verified, and the cRNA concentration estimated, by denaturing agarose gel electrophoresis. Oocytes were isolated from X. laevis (Pacific Biological, Sherman Oaks, CA) ovaries by collagenase treatment. Stage V-VI oocytes were selected and manually defolliculated if necessary. After a 24-h incubation in ND-96 medium to ensure viability, a Nanoject apparatus (Drummond, Broomall, PA) was used to inject oocytes with 46 nl of 0.05-0.5 g/l Cx31.9 cRNA and 5 ng of Cx38 antisense oligonucleotide (5Ј-GCTTTAGTAATTCCCATCCTGC-CATGTTTC-3Ј) to block endogenous connexin synthesis (24) . Injected oocytes were incubated for 48 h, followed by manual removal of the vitelline layers. Oocytes were paired at their vegetal poles for 2-6 h, and junctional conductance between oocytes was measured with the dual voltage clamp technique as previously described (25), using dual Gene Clamp 500Bs driven by a D/A board under the control of Pclamp 8.0 data acquisition software (Axon Instruments, Foster City, CA). Each oocyte in a pair was initially clamped to a potential equal to the average of the two resting potentials, and one oocyte was stepped to a series of voltages to generate a series of transjunctional potentials. Junctional currents were recorded as the currents induced in the nondriven oocyte.
Electrophysiology of Cx31.9 Overexpressed in HEK Cells
A dual cell voltage clamp method was used (26 -28) . Poly-L-lysinecoated coverslips containing cells were mounted on the stage of an inverted Nikon Diaphot fluorescent microscope equipped with Hoffman modulation optics. The cells were perfused with Krebs-Ringer solution (140 mM NaCl, 4.5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , pH 7.2) at room temperature immediately prior to each experiment. Patch pipettes were pulled from glass capillary tubes with filaments to a resistance of 1-2 megohms. The pipettes were filled with solution containing 160 mM potassium aspartate, 1.1 mM EGTA, 2 mM MgCl 2 , 0.1 mM CaCl 2 , 10 mM Hepes, pH 7.2. Data were collected using an ADLab D/A board driving two Axopatch (1B and C) patch clamps (Axon Instruments) in voltageclamp mode. Voltage protocols and data collection were controlled by home-made software. For evaluation of junctional conductance, both cells were held at Ϫ40 mV, and 50-ms pulses to Ϫ20 mV were alternately applied to each cell. Cells examined were generally in contact only with each other, but occasionally two adjacent cells in a chain were selected. The electrical conductance was calculated as the junctional current divided by the potential difference between the two cells. In some cases, IV curves were generated by stepping the voltage in one cell while holding the other cell at a fixed value.
ZO-1/Cx31.9 Co-immunoprecipitation
Cx31.9-HEK and wt HEK cells were treated as above (immunoprecipitation analysis), without the radiolabel. The IP buffer has been optimized by Giepmans and co-workers (14) to retain the interaction of Cx43 and ZO-1, while minimizing nonspecific interactions. Following immunoblot transfer, ZO-1 was detected using a commercial polyclonal antibody (Zymed Laboratories). For the detection of immunoprecipitated Cx31.9, mAb 7G6 was biotinylated using NHS-PEO 4 -Biotin (Pierce) according to the instructions from the manufacturer. The biotinylation was done to avoid reactivity of secondary anti-mouse antibody with the light chains of antibodies used for the immunoprecipitation. Biotinylated 7G6 was detected using Vectastain Elite ABC kit with peroxidase (Vector Laboratories, Inc., Burlingame, CA) and chemiluminescence, according to the instructions from the manufacturer.
ZO-1-PDZ Pull-down Assay
PDZ-GST fusion proteins were prepared using standard procedures and bound to glutathione-agarose (Sigma). The agarose beads containing fusion proteins were then incubated with IP buffer lysates from a confluent 85-mm dish of Cx31.9-HEK cells overnight. After washing in IP buffer, the beads were eluted with SDS-PAGE sample buffer, separated by SDS-PAGE, and transferred to nitrocellulose membrane. Cx31.9 was detected with mAb 7G6.
RESULTS
Molecular Cloning of Cx31.9 -The human GenBank TM EST data base was searched with connexin motifs using the BLAST algorithm, and a number of clones encoding partial, putative novel connexins were identified. One of these clones, accession number AA915885 (derived from a human colon adenocarcinoma library), was purchased and fully sequenced in both directions by primer walking. The insert contained a sequence of 1499 bp, which consisted of a putative 5Ј-UTR (659 bp), an ATG codon flanked by G in position ϩ4 and A in Ϫ3, which was predicted to be a strong initiator of translation (29), and an open reading frame (840 bp). However, the open reading frame was not complete, but was followed by a NotI site, indicating that this was a partial clone formed by restriction digestion of the cDNA during library synthesis. The sequence of clone AA915885 was also similar to human EST clone AI142991 (from a human senescent fibroblast library).
Clone AA915885 was used to screen a human genomic library, and four clones were identified. Restriction digests from these clones were analyzed by Southern blots, and a 1949-bp BamHI fragment was subcloned and fully sequenced in both directions. This genomic fragment contained an open reading frame identical to clone AA915885 and additional coding sequence including a stop codon (Fig. 1) . The open reading frame encoded a putative 294-amino acid protein, with a predicted molecular mass of 31,933. This protein will be referred to as Cx31.9 in accordance with the nomenclature previously proposed for connexins (6) .
A comparison of the Cx31.9 genomic and EST clone revealed that no introns were present in the coding sequence of Cx31.9, as is the case for all connexins except Cx36 (30) and Cx40.1. 3 Furthermore, no introns were found in the 249 bp upstream of the initiating ATG codon contained in the genomic clone. This was surprising, because all mammalian connexins characterized to date contain one, or two (Cx45, Ref. 31), intron(s) in the 5Ј-UTR in close proximity to the initiating ATG codon. To verify that clone AA915885 had been properly spliced, testis cDNA was used for 5Ј-RACE. The major PCR product contained 859 bp upstream of the initiating ATG codon of Cx31.9. This sequence also aligned with the most 5Ј 659 bp of clone AA915885, confirming that there was no intron in this region (data not shown). However, putative strong splice acceptor sequences were located at position Ϫ5, and potential lariat forming branch sites were found at positions Ϫ25 and Ϫ42. Furthermore, a weaker splice acceptor was found at position Ϫ53, with a potential branch site at position Ϫ70. This raises the possibility that the 5Ј region may be spliced under certain circumstances.
During the course of this study, a human genomic sequence from a BAC clone containing the Cx31.9 gene was deposited in the GenBank TM data base under accession number AC090426. This clone has been localized to chromosome 17q21.1, a locus that does not contain any of the other connexin genes present in the human genome. The 859-bp 5Ј-UTR obtained by 5Ј-RACE aligns with the genomic sequence of this clone, consistent with the lack of introns in this region (data not shown).
Interestingly, another transcript appears to initiate within the 5Ј-UTR of Cx31.9. When the genomic sequence upstream of the Cx31.9 coding region was searched against the EST data base, a number of EST clones, e.g. BG027595, were found to have their most 5Ј end 459 bp upstream of the initiating ATG codon of Cx31.9, thus within the Cx31.9 5Ј-UTR. This mRNA was transcribed in the opposite direction of Cx31.9.
A human EST clone from an esophagus squamous cell carcinoma library (GenBank TM accession number AW08188) was identified corresponding to nucleotides 1081-1632 of the Cx31.9 genomic BamHI fragment, suggesting that Cx31.9 was expressed in several tissues.
Analyses of the Cx31.9 Protein Sequence-Hydrophobicity analysis of Cx31.9 suggested the presence of four putative transmembrane spanning domains (Fig. 1 ) similar to other connexins. The spacing of cysteine residues in the two extracellular domains, C(X 6 )C(X 3 )C (residues 54 -65), and C(X 4 )C(X 5 )C (residues 168 -179) are conserved in all connexins (except Cx31). Several consensus motifs for potential post- 
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translational modifications were identified by searching the Cx31.9 sequence against the PROSITE data base. Four potential PKC ((S/T)X(R/K)) phosphorylation sites were identified in the COOH terminus at residues 252, 272, 278, and 287, as well as a casein kinase II (SXXE) phosphorylation site at residue 272. To compare the sequence of Cx31.9 to other connexins, we first searched the GenBank TM human genomic data base for all connexin genes present in the human genome. In total, 20 putative human connexins were identified, several of which have not been previously characterized.
2 These 20 genes appear to be similar to those recently reported by Willecke et al. (21) . The overall amino acid sequence similarity between Cx31.9 and the other human connexins ranged from 48 to 60%, with 32-41% identical residues. The connexins most similar to Cx31.9 were members of the ␣-group of connexins. To elucidate the sequence relationship of Cx31.9 with its human paralogues, we aligned the connexins using ClustalW, and compared the conserved regions by phylogenetic analysis. Using this method, Cx31.9 was also found to group with the ␣-group of connexins (Fig. 2) and was designated connexin ␣11.
Northern Analysis-A probe encompassing the 3Ј end of the Cx31.9 coding region, which showed no homology to other connexins, was used for Northern blot analysis of human poly(A) ϩ RNA. The major signal detected was a 4.4-kb band, which was seen in all tissues examined, although with varying intensities (Fig. 3, arrowhead) . The highest expression levels were found in heart and pancreas. Lower intensity bands were also detected at 1, 0.5, and 0.4 kb. Although we cannot exclude that these bands represent nonspecific hybridization of the probe, this seems unlikely because of their correlation with the intensity of the 4.4-kb transcript. Although most connexin transcripts migrate as single bands in Northern analysis, more than one transcript size has also been detected for human Cx45 (32) and mouse Cx31 (33) . However, because of the small size of the Cx31.9 bands, they were more likely generated by degradation of the RNA than by alternative splicing. Reprobing of the blot with a probe against ␤-actin showed that comparable amounts of poly(A) ϩ RNA were loaded in all lanes (Fig. 3, lower  panel) .
Generation of mAbs against Cx31.9 -The intracellular loop (residues 95-136; Cx31.9 L-GST), and COOH-terminal domain (residues 207-294; Cx31.9 Ct-GST) of Cx31.9 were expressed as GST fusion proteins. The fusion proteins showed a decrease in SDS-PAGE mobility compared with GST alone, which corresponded approximately to the predicted mass of the domains (Fig. 4A, lower panel) . In Cx31.9 L-GST, a second band migrating faster than GST alone was also observed. This band likely represented a cleaved form of the fusion protein, although other possibilities, such as a co-purified interacting protein, cannot be excluded. mAbs were generated against these fusion proteins. Six hybridomas that produced antibodies reactive with Cx31.9 Ct-GST were identified and found to react similarly in all assays. Only one, mAb 7G6 (IgG), was further characterized. mAb 7G6 reacted with Cx31.9 Ct-GST (Fig. 4A, upper panel, lane 1) but not with GST (Fig. 4A, upper panel, lane 2) or Cx31.9 L-GST (Fig. 4A, upper panel, lane 3) in immunoblot analysis. From the fusion of the mouse immunized with Cx31.9 L-GST, only one hybridoma that secreted an antibody reactive with Cx31.9 L-GST was identified. This mAb, 5G11 (IgG), reacted with Cx31.9 L-GST (Fig. 4A, upper panel, lane 6 ), but not with GST or Cx31.9 Ct-GST alone (Fig. 4A, upper panel, lanes 4 and 5) in immunoblot analysis.
Characterization of mAbs 7G6 and 5G11 by Immunoprecipitation-To further determine the specificity of mAbs 7G6 and 5G11, these mAbs were used in immunoprecipitation experiments with HEK 293 cells stably overexpressing Cx31.9, and wt HEK cell lysates. A small aliquot of radiolabeled lysate from each cell line was analyzed by SDS-PAGE and autoradiogra- TM genomic data base. Cx31.9 is underlined, and was found to cluster with the ␣-group of connexins. The tree was obtained by analysis of the conserved regions between connexins. Sequences were aligned using ClustalW, and the average similarity between aligned sequences was calculated for each sequence segment (using a previously described algorithm; see saier-144 -37.ucsd.edu/ biotools/avehas.html). Sequence segments having less than 25% similarity were excluded from the analysis (most of the intracellular loops and COOH-terminal domains). FIG. 3 . Northern blot analysis of Cx31.9 expression. A CLON-TECH MTN I blot was probed with the 3Ј end of the Cx31.9 coding sequence. The major signal detected was a 4.4-bp band (arrowhead), which was seen in all tissues after long exposure of the blot (data not shown). Reprobing for ␤-actin confirmed that comparable amounts of mRNA were loaded (lower panel). The faster migrating forms of ␤-actin observed in heart and skeletal muscle are splice variants previously described (34) .
phy. The lysates were found to contain equal amounts of radiolabel and showed uniform labeling of proteins (Fig. 4B, lanes 1  and 5) . Both mAb 7G6 and mAb 5G11 were able to immunoprecipitate a protein migrating at 30 -33 kDa from Cx31.9-HEK cells (Fig. 4B, lanes 2 and 3, black arrowhead) . No proteins with this mass were immunoprecipitated from wt HEK cells (Fig. 4B, lanes 6 and 7) , suggesting that the immunoprecipitated protein from Cx31.9-HEK cells was indeed Cx31.9. Furthermore, Cx31.9 was not immunoprecipitated using the same amount of an irrelevant mouse antibody, indicating that mAbs 7G6 and 5G11 were both specific for Cx31.9. This experiment was also carried out using RIPA buffer. mAb 7G6 immunoprecipitated Cx31.9 equally efficient using both buffers, whereas very little Cx31.9 was immunoprecipitated with mAb 5G11 in RIPA buffer (data not shown).
A protein migrating at 25 kDa was also immunoprecipitated with mAb 5G11 from Cx31.9-HEK cells, but not from wt HEK cells, and not by mAb 7G6 (Fig. 4B, white arrowhead) . This protein possibly represented a cleaved form of Cx31.9, which lacked the COOH-terminal domain, and therefore was not recognized by mAb 7G6.
Immunoblot Analyses of Cx31.9 in Overexpressing Cells and Human Tissues-A fusion protein of Cx31.9 with eGFP as a COOH-terminal tag (Cx31.9-eGFP), and untagged Cx31.9 were transiently expressed in HeLa cells. Lysates from these cells, and lysates from Cx31.9-HEK and wt HEK cells, were analyzed by immunoblot with mAb 7G6. A protein migrating at 30 -33 kDa was detected in Cx31.9-transfected cells (Fig. 5A, lanes 2  and 5, arrowhead) , but not in wt HeLa or wt HEK cells (Fig. 5A,  lanes 1 and 4) . wt HEK cells transiently expressing Cx43 from the same expression vector also contained no protein in this range reactive with mAb 7G6 (data not shown). In Cx31.9-eGFP-expressing cells, a protein migrating at 53 kDa (Fig. 5A,  lane 3, arrow) was detected. The migration of this protein was within the range expected from the composite weight of Cx31.9 and eGFP (58.9 kDa). The amount of protein loaded was visualized by reprobing the blot with an antibody against ␣-actin, which showed that comparable amounts of protein were loaded in all lanes (Fig. 5 A, lower panel) .
When mAb 5G11 was applied to similar immunoblots, no proteins were detected despite applying large amounts of antibody (data not shown). This suggested that the mAb 5G11
FIG. 4. Characterization of mAbs 7G6 and 5G11 against Cx31.9.
A, mAb 7G6 and 5G11 immunoblot analysis of Cx31.9-GST fusion proteins. The proteins analyzed were as follows: lanes 1 and 4, fusion proteins containing the COOH terminus of Cx31.9 (Cx31.9 Ct-GST); lanes 2 and 5, GST; lanes 3 and 6, the loop region of Cx31.9 (Cx31.9 L-GST). mAb 7G6 only reacted with Cx31.9 Ct-GST, whereas mAb 5G11 only reacted with Cx31.9 L-GST (upper panels). Ponceau staining of the blots showed that the Cx31.9 domains changed the SDS-PAGE mobility of GST fusion proteins as expected (lower panels). B, immunoprecipitation of 35 S-labeled Cx31.9 from overexpressing HEK cells. Cells were metabolically labeled and lysed in buffer containing 1% Nonidet P-40, 0.25% deoxycholate. mAb 7G6, 5G11, and an irrelevant mAb (5 g each) were used for the immunoprecipitations. Lysates were analyzed to verify uniform labeling (lanes 1 and 5) . Cx31.9 was immunoprecipitated by both mAb 7G6 and mAb 5G11 from Cx31.9-HEK cells, but not from wt cells (black arrowhead). A 25-kDa protein was also present in mAb 5G11 immunoprecipitates from Cx31.9-HEK cells (white arrowhead), possibly representing a proteolytic fragment of Cx31.9 lacking the COOH-terminal domain. , and skeletal muscle (lane 5) were analyzed. Cx31.9 was detected in heart, colon, and artery, but not in brain and skeletal muscle (arrowhead). Reprobing of the blot for actin showed comparable amounts of protein in all lanes (lower panel) epitope was conformation-dependent and was destroyed by SDS when present in intact Cx31.9, but not when expressed as the Cx31.9 L-GST fusion protein. The low immunoprecipitation efficiency of mAb 5G11 in RIPA buffer was consistent with this hypothesis.
To investigate the expression of Cx31.9 in human tissues, immunoblots containing lysates from human tissues were analyzed using mAb 7G6. Because of the difficulties encountered in obtaining human tissue samples of adequate quality, only a limited number of tissues were available for this study. A protein migrating at 30 -33 kDa was detected in human heart, colon, and artery, but could not be detected in human brain and skeletal muscle (Fig. 5B, upper panel, arrowhead) . The blot was reprobed with an antibody against actin, which demonstrated that similar amounts of lysates had been analyzed (Fig. 5B,  lower panel) . A similar blot probed with an irrelevant mouse IgG antibody revealed no bands migrating in this range (data not shown).
Immunofluorescence of Cx31.9-overexpressing HEK Cellswt HEK cells transiently expressing Cx31.9-eGFP, or eGFP alone, were analyzed by fluorescent confocal microscopy. In a low proportion of cell pairs expressing Cx31.9-eGFP, structures resembling gap junction plaques were observed (Fig. 6A, arrow) . In contrast, cells expressing eGFP alone showed diffuse fluorescence in intracellular compartments (Fig. 6C) .
Cx31.9-HEK cells were analyzed by confocal immunofluorescence with mAbs 7G6 and 5G11. mAb 7G6 was found to stain mainly large gap junction-like structures (Fig. 6E, arrow) , and intracellular puncta. No significant staining was seen in wt HEK cells with mAb 7G6 (Fig. 6G) , or in either cell line with an irrelevant mouse IgG mAb (data not shown). mAb 5G11 was also found to stain mainly gap junction-like structures in Cx31.9-HEK cells (Fig. 6I, arrow) , and showed no significant staining in wt HEK cells (Fig. 6K) . The staining of mAb 7G6 was similar whether the cells had been fixed in 4% paraformaldehyde, methanol, or acetone, whereas mAb 5G11 only worked well with acetone fixation.
Immunohistology of Human Tissue Sections Using mAbs 7G6 and 5G11-Frozen human tissue sections of normal testis, brain, and tonsil were examined with mAb 7G6 and mAb 5G11 by confocal immunofluorescence. In all three tissues mAb 7G6 reacted with blood vessels (Fig. 7, A, D, and G) . No staining of these structures was observed with an irrelevant IgG mAb (data not shown). To identify the cell types recognized by mAb 7G6, co-labeling was done with mAb 1E12, which reacts with smooth muscle ␣-actinin (35) . Extensive co-localization was observed between mAb 7G6 and 1E12 (Fig. 7, A, B, D, E, G, and  H) , indicating that mAb 7G6 reactivity was localized to smooth muscle cells. Controls included staining with primary antibodies separately, and with secondary antibodies separately (data not shown). Staining with mAb P2B1, which recognizes the endothelial cell marker PECAM (36), labeled capillaries or lymphatic vessels, which do not contain smooth muscle cells (Fig. 7J, arrows) , as well as the endothelial cells in the larger vessels that contained smooth muscle cells. Staining of adjacent sections with PECAM antibodies (mAb P2B1) showed more extensive staining than mAb 7G6 (indicated by arrows in Fig. 7J when compared with Fig. 7G) , because of the labeling of capillaries or lymphatic vessels by mAb P2B1. These results indicated that mAb 7G6 stained smooth muscle cells, but not endothelial cells.
Upon acetone fixation of these sections, mAb 5G11 stained vascular smooth muscle cells in testis (Fig. 7L) as well as in brain and tonsil (data not shown), in accordance with the staining pattern of mAb 7G6. This suggests that Cx31.9 is mainly expressed by vascular smooth muscle cells.
Functional Characterization of Cx31.9 Gap Junctions: Dye
Transfer-Confluent cultures of Cx31.9-HEK cells and wt HEK cells were microinjected with the fluorescent tracers Lucifer yellow (M r 457, net charge Ϫ2), carboxyfluorescein (M r 376, net charge Ϫ1), cascade blue (M r 596, net charge Ϫ3), and ethidium bromide (M r 394, net charge ϩ1), and dye spread was monitored in a fluorescent microscope. These dyes have previously been shown to permeate some gap junctions. Fluorochromelabeled dextran, which does not permeate gap junctions because of its size, was included in the injected solution, to identify the injected cell. No dye transfer beyond the spread of dextran was observed in wt HEK cells, or in 10/10 injections for each dye in Cx31.9-HEK cells (data not shown).
Expression of Cx31.9 in Xenopus Oocytes-To examine the functionality of Cx31.9 channels, we expressed Cx31.9 in Xenopus oocytes, and assayed for the presence and properties of gap junction-mediated electrical coupling between oocyte pairs. RNA containing the Cx31.9 coding sequence, flanked by 5Ј-and 3Ј-UTR sequences from the X. laevis ␤-globin gene, was transcribed in vitro, and injected in oocytes together with a Cx38 antisense oligonucleotide, to reduce the coupling effect of endogenous oocyte connexin. Significant cell-to-cell conductances 
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were detected in oocyte pairs injected with Cx31.9 cRNA, whereas no conductances were detected in pairs of uninjected oocytes. Oocyte pairs injected with 0.05 g/l Cx31.9 cRNA showed cell-to-cell conductances ranging between 0.1 and 0.9 S, whereas oocyte pairs injected with 0.5 g/l Cx31.9 cRNA showed conductances between 0.3 and 11.3 S. The average conductances for oocyte pairs increased with the concentration of injected Cx31.9 cRNA (Table I) , further indicating that the observed gap junctional coupling resulted from Cx31.9 and not from any endogenously expressed component. The voltage-dependent properties of Cx31.9 channels were then examined and compared with the properties of previously reported gap junction channels. Interestingly, Cx31.9 gap junctions showed very little sensitivity to voltage as demonstrated by the family of junctional currents induced by imposing a series of transjunctional potentials in oocyte pairs ranging from Ϫ180 to ϩ120 mV (Fig. 8A) . Note that any reduction in junctional current was only seen at very large transjunctional potentials (greater than Ϯ120 mV). The absence of strong voltage-dependent gating was confirmed by a scatter plot (Fig. 8B) of the normalized initial (squares) and near steady-state (circles) junctional conductances from six different Cx31.9-injected oocyte pairs. Because the voltage dependence was weak and never resulted in reduction of the conductance to more than about 80% of its initial value, we did not attempt the traditional Boltzmann fit of the data. These results were similar for both concentrations of Cx31.9 cRNA injected, and for all levels of macroscopic conductance, suggesting that the lack of voltage dependence is not an artifact arising from increased access resistance that may be associated with larger gap junction plaques and larger total whole cell junctional conductances.
It should be noted that we consistently observed asymmetry in the voltage dependence of the instantaneous conductance, but it is difficult to ascertain exactly what this asymmetry represents. One possibility is that Cx31.9 gap junction channels are sensitive to the membrane potential in addition to the transjunctional potential and undergo V m gating. However, the initial conductance is not monotonically dependent on V m as is the case for other connexins that show V m sensitivity. Rather, we found that the normalized initial conductance increased only for negative transjunctional potentials and was most prominent only for the largest voltages. Under these specific conditions, which arise from depolarizing the driven oocyte to voltages greater than ϩ60 mV, we also observed the activation of large outward currents in the plasma membrane of the driven oocyte originating from endogenous channels (data not shown). It is therefore possible that the asymmetry we observed in the instantaneous conductance is an artifact introduced by the activation of large endogenous currents.
Double Whole Cell Patch Clamping-To verify that Cx31.9 also formed gap junction channels in mammalian cells, and to confirm the lack of voltage dependence of Cx31.9 channels observed in the oocyte system, we examined the electrophysiological properties of Cx31.9-HEK versus wt HEK cells, using double whole cell patch clamping. We used HEK293 cells for this purpose, because these cells have previously been reported to express very low levels of Cx43, and to exhibit minimal coupling (13, 37) . We recorded data on two types of cell pairs, either isolated pairs, or pairs of cells located in a string of cells, such that neither of the two cells contacted any cell that contacted both members of the pair. Using these pairs allowed a reasonable accurate estimate of junctional conductance, but could give rise to small series resistance errors as a result of lowered effective input impedance of the driven cell. Such errors would result in underestimates of the junctional conductance.
The voltage in both cells was initially clamped to the same holding potential (in the range from 0 to Ϫ60 mV, but usually Ϫ40 mV). Junctional current, I j , was measured during periodic Two different concentrations of Cx31.9 cRNA (0.05 and 0.5 g/l) were injected in oocytes together with a Cx38 antisense oligonucleotide. Increased junctional conductances were observed with increased amounts of Cx31.9 cRNA injected. Connexin-31.9
positive and/or negative pulses of transjunctional voltage, V j . The junctional conductances, G j , of Cx31.9-HEK cell pairs varied between 5 and 125 nS, with a mean value of 29.6 nS (n ϭ 15) and a standard deviation of 30 nS. The G j of wt HEK cells varied from 0 nS to 50 nS, with a mean value of 13.2 nS (n ϭ 7) and a standard deviation of 18 nS (Fig. 9A) . Thus, the highest junctional conductances and a higher average conductance were seen in Cx31.9-transfected cells, indicating that Cx31.9 channel expression was associated with increased junctional conductance. The standard deviation of the junctional conductances of transfected cell pairs was also higher than of wt cells, suggesting that transfection resulted in variable, significantly higher levels of junctional conductance than those seen in wt cells. However, we cannot exclude that the highest junctional conductances from both Cx31.9-expressing and wt cells were caused by cytoplasmic bridges. The residual background junctional conductance of wt HEK cells was probably contributed by endogenous Cx43. Using Cx31.9-HEK cell pairs, we confirmed the lack of voltage dependence of the current seen in the paired oocyte experiments. Fig. 9B shows the current response of the non-driven cell, held at 0 mV, whereas the driven cell was subjected to a series of voltage pulses from 160 mV to Ϫ120 mV in 40-mV steps. None of the IV curves, generated by similar, but not identical protocols, from nine different Cx31.9-transfected HEK cell pairs showed significant voltage dependence. In some cases we were not able to measure complete current voltage curves, but were able to estimate junctional conductance from a voltage protocol in which each cell was held at Ϫ40 mV while the other was pulsed to Ϫ20 mV. Thus, the electrophysiological results from two different expression systems confirm that Cx31.9 induces formation of voltage-independent cell-to-cell coupling within a physiologically relevant range.
Cx31.9 Binding to ZO-1-The most COOH-terminal sequence of Cx31.9 contained a motif (RDLAI) that resembled the COOH-terminal sequence of Cx43 (DDLEI). The most COOHterminal isoleucine residue of Cx43 has been shown to be critical for binding to the second PDZ domain of ZO-1 (14) . Based on this, we addressed whether Cx31.9 also interacted with ZO-1. Double immunoconfocal staining for ZO-1 and Cx31.9 in Cx31.9-HEK cells showed that most ZO-1 staining co-localized to membrane domains with cell-cell contact and Cx31.9 gap junctions (Fig. 10A) . However, cell membrane staining of ZO-1 was also occasionally found where no Cx31.9 gap junctions were detected (data not shown), and no ZO-1 co-localization was observed with Cx31.9 in intercellular compartments (Fig. 10A ). This showed that Cx31.9 was partially co-localized with ZO-1. We then examined whether ZO-1 coimmunoprecipitated with Cx31.9. Immunoblot analysis showed that ZO-1 was present in equal amounts in lysates from both Cx31.9-HEK and wt HEK cells (Fig. 10B, upper panel,  lanes 1 and 5) . ZO-1 was found to co-precipitate with Cx31.9 which was pulled down using both mAb 7G6 and 5G11 (Fig.  10B, upper panel, lanes 3 and 4) , whereas ZO-1 was not immunoprecipitated from wt HEK cells (Fig. 10B, upper panel, lanes  6 and 7) . An irrelevant antibody did not immunoprecipitate ZO-1 (Fig. 10B, upper panel, lane 2) . Ponceau staining of the blot showed that similar amounts of antibodies had been used (Fig. 10B, middle panel) . Cx31.9 was detected in the immunoprecipitations of mAbs 7G6 and 5G11 from Cx31.9-HEK cells with biotinylated mAb 7G6, as expected (Fig. 10B, lower panel) . Interestingly, although severalfold more Cx31.9 was precipitated with mAb 7G6 than with mAb 5G11, the amount of FIG. 8 . Electrophysiological analyses of Xenopus oocytes expressing Cx31.9. Voltage-dependent properties of Cx31.9 channels formed between paired X. laevis oocytes. A, an example of junctional currents elicited in the non-driven oocyte by voltage pulses applied to the driven oocyte ranging from Ϫ180 mV to ϩ120 mV in 30-mV increments from a Ϫ40 mV holding potential. The transjunctional potential across gap junction channels ranged from ϩ140 mV to Ϫ160 mV relative to the cytoplasmic side of the non-driven oocyte. B, the G j -V j relationship for Cx31.9 gap junction channels. Initial and approximate steady-state conductances were obtained by dividing the junctional current at 30 ms and 5 s, respectively, by the transjunctional potential (V j ) as determined by the difference between the measured voltages of the two oocytes. Initial and steady-state conductances were then normalized to their respective values at Ϯ10 mV and plotted against V j . Voltage dependence with slow kinetics is evident only at large, nonphysiological voltages. co-precipitated ZO-1 was nearly identical in the two samples. This could be the result of a partial steric hindrance of mAb 7G6 binding to Cx31.9 when complexed with ZO-1.
These experiments suggested that ZO-1 interacted directly or indirectly with Cx31.9. Reprobing of these blots with an antibody against Cx43 revealed small amounts of Cx43 in the lysates, but this was not co-immunoprecipitated with Cx31.9 (results not shown), excluding that ZO-1 was co-immunoprecipitated because of the presence of heteromeric Cx31.9/Cx43 connexons. To determine which domains of ZO-1 interact with Cx31.9, GST fusion protein pull-down assays were performed with the first, second, and third PDZ domains of ZO-1. These experiments demonstrated that the second PDZ domain interacts with Cx31.9 (Fig. 10C, upper panel, lane 3) , whereas the first and third PDZ-domain did not (Fig. 10C, upper panel,  lanes 2 and 4) . Ponceau staining of the blot showed that similar amounts of fusion proteins had been used (Fig. 10C, lower  panel) . Interestingly, in similar experiments using lysates of HEK cells overexpressing Cx31.9-eGFP, Cx31.9-eGFP could be detected in the lysate as shown earlier (Fig. 5A) , but was not pulled down by any of the PDZ domains from ZO-1 (data not shown). These experiments suggested that the most COOHterminal residues of Cx31.9 interacted with the second PDZ domain of ZO-1, and that these residues were made unavailable for binding by the eGFP tag. Similarly, addition of a COOH-terminal Myc tag and green fluorescent protein tag to Cx43 has been reported to disrupt binding to ZO-1 (14) .
DISCUSSION
In the present study a novel human connexin gene, designated Cx31.9, was cloned and characterized. A mAb against Cx31.9 detected a protein with the expected SDS-PAGE mobility from human tissue lysates, suggesting that Cx31.9 is a bona fide gene. We furthermore showed that Cx31.9 forms functional gap junctions and is expressed in vascular smooth muscle cells. One unusual feature of the Cx31.9 gene is the probable lack introns in the 5Ј-UTR. We cannot exclude the possibility that the 5Ј-UTR could be spliced in some instances, because potential splice acceptor sites were present close to the initiating ATG codon. However, a spliced form is unlikely to represent a large proportion of Cx31.9 transcripts, because only one major transcript size was detected by Northern analysis (Fig. 3) .
The existence of a separate transcript, originating within the 5Ј-UTR, and being transcribed in the opposite direction of Cx31.9, was also unusual, and has to our knowledge not been described for other connexin genes. Transcription of this gene would be expected to be incompatible with simultaneous transcription of Cx31.9.
Given the abundance of the Cx31.9 transcript by Northern blot analysis, it was surprising that we only identified three Cx31.9 EST clones in GenBank TM . This may be a result of the following. 1) The transcript was larger than most published connexins, which reduces the number of (partially sequenced) ESTs containing the coding sequence. 2) The GC content of the coding region of Cx31.9 was 76%, which is higher than any other connexin gene. The high GC content could reduce the efficiency of cDNA synthesis, thereby under representing the sequence in cDNA libraries. Furthermore, the high GC content could make sequencing difficult, which may have contributed to sequences from Cx31.9 EST clones being discarded because of poor sequence quality. 3) It is possible that more EST clones containing the most 3Ј end of the Cx31.9 transcript exist in GenBank TM . Analysis of the Cx31.9 protein sequence showed a number of similarities to other connexins. The presence of four transmembrane domains, conserved spacing of cysteine residues in the extracellular domains, and a number of potential phosphorylation sites in the COOH-terminal domain. Cx31.9 also contained a stretch of 10 proline residues in the COOH-terminal domain (residues 238 -248). This domain is possibly involved in protein-protein interactions, because proline-rich sequences are known to bind to a number of specific protein interaction modules, such as Src homology 3 domains (38) .
Analysis of amino acid similarities in domains conserved between connexins placed Cx31.9 in the ␣-group of connexins (Fig. 2) . However, when the full sequences were compared, Nuclei are shown in each image. When the two stains were superimposed (data not shown), extensive co-localization of ZO-1 and Cx31.9 was observed at gap junctions between cells (arrows). B, co-immunoprecipitation of ZO-1 with Cx31.9. Cx31.9-HEK and wt HEK cell lysates were used in immunoprecipitation analyses with mAbs 7G6, 5G11, and an irrelevant mAb. ZO-1 was immunoprecipitated with mAb 7G6 and mAb 5G11 (lanes 3 and 4) , but not with an irrelevant mAb (lane 2, upper panel). Ponceau staining of the blot showed similar amounts of antibodies in all samples (middle panel). The membrane was reprobed with biotinylated mAb 7G6 to monitor the amount of Cx31.9 in the immunoprecipitates (lower panel). Cx31.9 was detected in mAb 7G6 and mAb 5G11 immunoprecipitates (lanes 3 and 4) . C, pull-down experiment with Cx31.9 and PDZ domains from ZO-1. PDZ domains were expressed in bacteria as GST fusion proteins, and incubated with Cx31.9-HEK cell lysates. Proteins bound to fusion proteins were separated by SDS-PAGE, and Cx31.9 was detected with mAb 7G6 in immunoblot analysis. The second PDZ domain bound to Cx31.9 (lane 3, upper panel). Fusion proteins were visualized by Ponceau staining of the blot (lower panel).
Cx31.9 had a shorter cytoplasmic loop and COOH-terminal domain than the other members of the ␣-group. The cytoplasmic loop of Cx31.9 consisted of 37 amino acid residues, but contained 50 -58 amino acid residues for the other members of the ␣-group. The members of the ␤-group of connexins had cytoplasmic loops containing 30 -38 residues, and were thus more similar to Cx31.9 in this respect. The significance of these differences is not clear.
Immunostaining of human tissue sections with mAb 7G6 indicated that Cx31.9 was mainly expressed in vascular smooth muscle, and this was further corroborated by immunostaining with mAb 5G11. The ubiquitous expression pattern of the Cx31.9 transcript was consistent with expression in vascular smooth muscle (and cardiac myocytes). Furthermore, there was a correlation of Cx31.9 expression levels, as detected by Northern and immunoblot analysis of human tissues. mAb 7G6 detected Cx31.9 in heart lysates, but not in lysates from brain and skeletal muscle, consistent with the expression levels of Cx31.9 transcripts observed by Northern analysis (Fig. 3) .
Notably, the organ expression pattern of Cx31.9 as determined by Northern analysis differed from the organ expression patterns of other connexins also found in smooth muscle cells, such as Cx43, Cx40, and Cx45 (39, 40) . For example, although the expression of Cx31.9 is low in lung (Fig. 3) , Cx40 is highly expressed in this organ by Northern analysis (33, 41) . Because several different cell types are present in the lung, one possible explanation for this difference is that endothelial cells are the main cells expressing Cx40 in lung, whereas these cells do not express Cx31.9. To further investigate whether Cx31.9 was expressed by endothelial cells, adjacent human tissue sections were stained for an endothelial cell marker (PECAM), and with mAb 7G6. No co-localization of PECAM with mAb 7G6 was observed in capillaries or lymph endothelial cells (Fig. 7, G and  J) . Furthermore, we could not detect Cx31.9 expression in second passage human umbilical vein endothelial cells with mAb 7G6. These endothelial cells have been reported to express Cx37 and Cx40 (42) . Taken together, this suggested that Cx31.9 is not highly expressed, if at all, by endothelial cells. Interestingly, the expression levels of mouse Cx45 in lung is relatively high by Northern analysis (33) , and is confined to tracheo-bronchial smooth muscle (40) . Whether Cx31.9 is expressed in tracheo-bronchial smooth muscle remains to be determined, but a comparison of the Cx31.9 and Cx45 expression levels in lung by Northern analyses suggests that Cx31.9 may not be expressed by this type of smooth muscle, barring possible species and regional differences of smooth muscle abundance in lung.
Cx31.9 forms functional gap junction channels, as shown by electrophysiological analyses in paired oocytes expressing Cx31.9, and in HEK cell pairs overexpressing Cx31.9. We found the average junctional conductance of Cx31.9-HEK cell pairs to be a slightly more than twice that of wt HEK cell pairs (29.6 versus 13.2 nS). The large variance in junctional conductance of Cx31.9-HEK pairs suggests that the efficiency of junctional coupling induced by transfection is quite variable. It is possible that some of the conductance observed between transfected cell pairs is not caused by Cx31.9, but to cytoplasmic bridges or Cx43. However, this cannot be the case for all of the pairs, because of the close correspondence in the voltage dependence observed for Cx31.9-HEK cell pairs and oocyte pairs expressing Cx31.9, suggesting that a majority of the currents seen between Cx31.9-HEK cell pairs are most likely caused by Cx31. 9 .
In contrast to other connexin channels, Cx31.9 channels showed no gating dependence of transjunctional voltage within a physiological relevant range, but only at extreme transjunctional voltages (Ͼ125 mV) (Figs. 8 (A and B) and 9B). The voltage independence of Cx31.9 channels was observed by expressing two different concentrations of Cx31.9 cRNA in oocytes and in Cx31.9-overexpressing HEK cells, indicating that the voltage independence was not an artifact of the expression systems.
The voltage-dependent gating of previously reported connexin channels have varied from very sensitive (e.g. Cx32), to much less sensitive (e.g. Cx43). Cx31.9 is the least voltagedependent connexin characterized to date. This property of Cx31.9 channels may be useful in studies aimed at elucidating the amino acid residues involved in voltage-dependent gating in other connexins.
Cx31.9 gap junctions were detected in overexpressing HEK cells by electrophysiological analyses (Fig. 9) , and by immunofluorescence (Fig. 6) . However, no dye transfer through these junctions was detected. The lack of observable dye transfer may be the result of a smaller Cx31.9 pore size or of selectivity, because several connexins have been reported to be impermeable to the dyes tested, e.g. Cx59 (43) and Cx45 (44, 45) .
Our results demonstrate that Cx31.9 interacts with ZO-1, most likely through a molecular mechanism similar to that described for Cx43 (14) . This interaction involves the most COOH-terminal residues of the connexin, which interact directly with the second PDZ domain of ZO-1. The recently reported interaction between Cx45 and ZO-1 may occur through a similar mechanism. Cx31.9 thus seems to be part of an increasing group of connexins that are found to interact with ZO-1. The biological functions of these interactions still remain to be elucidated, but may be involved in localizing gap junctions to specific membrane domains, such as the intercalated discs in cardiac myocytes (13) . Alternatively, ZO-1 may function to recruit signaling or regulatory proteins to gap junctions.
We have cloned the mouse orthologue of Cx31.9, which is a 274-amino acid protein with a predicted molecular mass of 30.26 kDa (Cx30.2). This sequence has also recently been deposited in the GenBank TM data base under accession number CAC93843 by Eiberger et al. To elucidate the role of this protein in smooth muscle function, we are currently generating a mouse with a targeted deletion of Cx30.2.
